Amy L. Burroughs sold $2.7M of Terns Pharmaceuticals (TERN)

Executed Jan 5, disclosed Jan 6, 1 day later.

Value, as filed

$2.7M

71,339 sh × $38.10

Executed

Jan 5

the trade date, as filed

Disclosed

Jan 6

1 day after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

AB Amy L. Burroughs Chief Executive Officer profile →

Amy L. Burroughs (Chief Executive Officer) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in TERN. The largest single filing was $2.7M of TERN (71,339 sh × $38.10, as filed), executed Jan 5.

The name

TERN TERN TERN · 6 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Amy L. Burroughs in TERN

TERNSALE Terns Pharmaceuticals, Inc. $681K
14,583 sh across 2 lots
Exec Mar 16
Filed Mar 17 · 5:30 PM ET TERNSALE Terns Pharmaceuticals, Inc. $482K
12,242 sh across 2 lots
Exec Feb 17
Filed Feb 18 · 5:30 PM ET TERNSALE Terns Pharmaceuticals, Inc. $2.5M
68,749 sh across 2 lots
Exec Jan 15
Filed Jan 16 · 5:30 PM ET TERNPURCHASE Terns Pharmaceuticals, Inc. $110K
15,450 sh × $7.15
Exec Dec 5 2024
Filed Dec 9 2024 · 5:30 PM ET